Speech-Language Pathologists in Broadalbin, NY Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Gail Lee Decicco, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Spring St, Broadalbin, NY 12025 Phone: 518-588-9227

Mrs. Patricia Diane Wojcicki Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 372 Ridge Rd, Broadalbin, NY 12025 Phone: 518-883-4776

Jill Hulett, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 401 Ridge Rd, Broadalbin, NY 12025 Phone: 518-774-5915

Ms. Susan Q Mcdonald, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 134 Woodside Ave, Broadalbin, NY 12025 Phone: 518-261-1656

Mrs. Ellen M Alric, MA, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Bridge St, Broadalbin, NY 12025 Phone: 518-954-2650

News Archive

What consumers really think about sustainable foods

Are consumers under too much pressure to be healthy? Has the global financial crisis sidelined the promotion of sustainable food? And how much do consumers actually know or care about the subject?

GTRI becomes Veriwave Gold Certified Partner for leveraging WaveDeploy solution

Global Technology Resources, Inc., a Colorado-based I.T. integration consulting group, has announced a formal agreement with one of its strategic partners, VeriWave Inc., making GTRI one of only a handful of Gold Certified Partners in the country. By being a Gold Certified Partner, this gives GTRI the ability to advance its healthcare professional services offerings to the next level.

SARS outbreak unlikely according to World Health Organization

The regional head of the World Health Organization said today that it was possible the region would experience SARS cases this winter, but he doubted the situation would be serious. "I don't think a large outbreak is likely," said Dr Shigeru Omi, Regional Director of WHO's Western Pacific Regional Office.

Scientists study the impact of nerve growth factors for treating Parkinson's disease

Scientists in the Academy of Finland's Neuroscience Research Programme have reported promising new results with potential implications for the treatment of Parkinson's disease. They have been studying the impacts of nerve growth factors in the treatment of PD, and their latest results show that a certain growth factor can be used to halt the progress of damage brought on by a nerve poison and possibly even restore the function of damaged cells.

Read more Medical News

› Verified 3 days ago